PlumX Metrics
Embed PlumX Metrics

Feasibility and acceptability of the multi-component P3-MumBubVax antenatal intervention to promote maternal and childhood vaccination: A pilot study

Vaccine, ISSN: 0264-410X, Vol: 38, Issue: 24, Page: 4024-4031
2020
  • 23
    Citations
  • 0
    Usage
  • 86
    Captures
  • 2
    Mentions
  • 0
    Social Media
Metric Options:   Counts1 Year3 Year

Metrics Details

Most Recent News

Australian-first model to improve maternal and childhood vaccination rates

An Australian-first antenatal vaccine communication model for midwives showed promise for increasing uptake of maternal and childhood vaccines, according to a pilot study.

Article Description

Pregnancy is a critical time for vaccine decision-making, but coverage remains suboptimal for maternal influenza (45–60%) and pertussis vaccination (65–80%) in Australia. The multi-component P3-MumBubVax intervention has been designed for Australian midwives to optimise antenatal vaccine discussions and improve maternal and childhood vaccine uptake. A pilot study was conducted to assess intervention feasibility and acceptability. P3-MumBubVax includes components at three levels: 1. Practice ('vaccine champions'; stickers to prompt and record vaccine discussions/delivery); 2. Provider (website with vaccine communication training; learning exercise; fact sheets; links to child vaccination resources); 3. Parent (SMS reminders; website; fact sheets). Midwives and pregnant women 18–22 weeks gestation were recruited at the Royal Women's Hospital, Melbourne. Post-intervention online surveys assessed intervention feasibility, implementation, acceptability and impact on vaccine uptake. Twenty-five midwives and 62 pregnant women were recruited and 19/25 midwives completed training. Surveys were returned by 18/25 midwives and 56/62 women. 14/18 midwives reported using the sticker prompts, 10/18 reported using or referring to the website, and 11/18 reported using the fact sheets. 48/56 pregnant women (86%) reported discussing influenza and 46/56 (82%) discussed pertussis vaccines with their midwives. These conversations were reported to be short (1–3 min) for 48/56 women (87%). All midwives were satisfied with the intervention and 17/18 reported feeling more confident discussing vaccines following the intervention. Women were very satisfied with SMS content (50/56; 94%) and timing (49/55; 89%), and with their vaccine discussions in general (34/56; 63%). However, 16/54 (30%) wanted more discussion about childhood vaccines. Self-reported maternal vaccine uptake was 82% (45/55) and 93% (51/55) for influenza and pertussis (baseline 2017–2018: 43% influenza, 60% pertussis) and 96% (50/52) of infants were fully vaccinated at 12 weeks. The P3-MumBubVax intervention is feasible and acceptable in the Australian public antenatal setting. Further evaluation is required to determine effectiveness.

Bibliographic Details

Kaufman, Jessica; Attwell, Katie; Tuckerman, Jane; O'Sullivan, Jacinta; Omer, Saad B; Leask, Julie; Regan, Annette; Marshall, Helen; Lee, Katherine J; Snelling, Tom; Perrett, Kirsten; Wiley, Kerrie; Giles, Michelle L; Danchin, Margie

Elsevier BV

Biochemistry, Genetics and Molecular Biology; Immunology and Microbiology; Veterinary; Medicine

Provide Feedback

Have ideas for a new metric? Would you like to see something else here?Let us know